Low-dose topical fluorouracil/salicylic acid versus diclofenac/hyaluronic acid in patients with actinic keratosis

Trial Profile

Low-dose topical fluorouracil/salicylic acid versus diclofenac/hyaluronic acid in patients with actinic keratosis

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2016

At a glance

  • Drugs Diclofenac/hyaluronic-acid; Fluorouracil/salicylic-acid
  • Indications Actinic keratosis; Skin cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Feb 2016 Results published in Cipher media release.
    • 27 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top